Yayın Ağı
SCI, SSCI ve AHCI İndekslerine Giren Dergilerde Yayınlanan Makaleler
A Chemical Agent Induced Retinal Degenerative Disease Animal Model for Gene Therapy
MOLECULAR THERAPY
, cilt.29, sa.4, ss.273-274, 2021 (SCI-Expanded)
Construction of Vasoactive Intestinal Peptide Encoding Lentiviral Gene Therapy Vector for Retinal Dystrophies
MOLECULAR THERAPY
, cilt.29, sa.4, ss.266, 2021 (SCI-Expanded)
Tip 1 diyabetli hastalarda insulin tedavisinde ve insulin gen terapisinde güncel gelişmeler
Turkish Journal of Medical Sciences
, cilt.1, sa.5, ss.1-5, 2012 (SCI-Expanded)
CLINICAL SIGNIFICANCE OF TRAIL AND TRAIL RECEPTORS IN PATIENTS WITH HEAD AND NECK CANCER
HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK
, cilt.33, sa.9, ss.1278-1284, 2011 (SCI-Expanded)
EXPRESSION PROFILES OF TRAIL LIGAND AND RECEPTORS IN ENDOMETRIAL CARCINOMA
IUBMB LIFE
, cilt.61, sa.3, ss.333, 2009 (SCI-Expanded)
MOLECULAR PROFILE OF TUMOR NECROSIS FACTOR-RELATED APOPTOSIS INDUCING LIGAND (TRAIL) AND ITS RECEPTORS ON T CELLS IN PATIENTS WITH RHEUMATOID ARTHRITIS
IUBMB LIFE
, cilt.61, sa.3, ss.327, 2009 (SCI-Expanded)
IN VIVO FLUORESCENT IMAGING OF ALLOGENEIC AND XENOGENEIC ISLET GRAFTS FOLLOWING TRANSPLANTATION
IUBMB LIFE
, cilt.61, sa.3, ss.378-379, 2009 (SCI-Expanded)
Tumor necrosis factor-related apoptosis inducing ligand-R4 decoy receptor expression is correlated with high Gleason scores, prostate-specific antigen recurrence, and decreased survival in patients with prostate carcinoma
UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS
, cilt.26, sa.2, ss.158-165, 2008 (SCI-Expanded)
Trail death receptor-4 expression positively correlates with the tumor grade in breast cancer patients with invasive ductal carcinoma
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
, cilt.69, sa.3, ss.716-723, 2007 (SCI-Expanded)
Testing the efficacy of substance P fragments as antitumor agents
DRUGS OF THE FUTURE
, cilt.32, ss.58, 2007 (SCI-Expanded)
The assessment of PTEN tumor suppressor gene in combination with Gleason scoring and serum PSA to evaluate progression of prostate carcinoma
UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS
, cilt.22, sa.4, ss.307-312, 2004 (SCI-Expanded)
PTEN as a diagnostic tool for the prognosis of prostate carcinomas
INTERNATIONAL JOURNAL OF CANCER
, ss.372, 2002 (SCI-Expanded)
ACTIVATION OF A PURKINJE-CELL SPECIFIC GENE BY HOMEOBOX PROTEINS
MOLECULAR BIOLOGY OF THE CELL
, cilt.6, ss.2000, 1995 (SCI-Expanded)
Diğer Dergilerde Yayınlanan Makaleler
Vasoactive Intestinal Peptide-mediated Gene Therapy for Diabetes
JOURNAL OF THE PANCREAS
, sa.15, ss.534, 2014 (Hakemli Dergi)
Hakemli Kongre / Sempozyum Bildiri Kitaplarında Yer Alan Yayınlar
Testing the efficacy of a novel adenovirus mediated TRAIL gene therapy approach for the treatment of patients with Type 1 Diabetes.
Advances in Molecular Medicine, İstanbul, Türkiye, ss.160
Testing the efficacy of a novel adenovirus mediated TRAIL gene therapy approach for the treatment of patients with Type 1 Diabetes.
Advances in Molecular Medicine, İstanbul, Türkiye, ss.160
Efficient adenovirus mediated TRAIL gene delivery into pancreatic islets as a model for the treatment of patients with type 1 diabetes
13th Annual Congress of European Society of Gene Therapy, Çek Cumhuriyeti, ss.74
TRAIL ligand and receptor expressions are differentially upregulated in prostate carcinoma patients: a significant issue for gene therapy of advanced prostate cancer
13th Annual Congress of European Society of Gene Therapy, Çek Cumhuriyeti, ss.22
Adenovirus mediated NF-kB inhibiting strategies for the treatment of patients with type 1 diabetes
13th Annual Congress of European Society of Gene Therapy, Çek Cumhuriyeti, ss.88
. “Expression Profile of TRAIL and its Receptors in Breast Cancer patients with invasive ductal carcinoma’’ Vol. 5 (4), EJC Supement Elsevier, 2007.
14th European Cancer Conference, İspanya, ss.2136
LentiVİP Gen Nakli Tip 1 Diyabetik Deneklerde Sistemik Enflamasyonu Baskılayarak Kan Şekerini Düşürdü
16. Ulusal Tıbbi Biyoloji ve Genetik Kongresi, Muğla, Türkiye, 27 - 30 Ekim 2019, ss.1
LentiVİP Gen Nakli Tip 1 Diyabetik Deneklerde Sistemik Enflamasyonu Baskılayarak Kan Şekerini Düşürdü
16. Ulusal Tıbbi Biyoloji ve Genetik Kongresi, Muğla, Türkiye, 27 - 30 Ekim 2019, ss.1
1- Lentivirus mediated insulin promoter directed insulin gene expression is effective in suppressing postprandial glucose excursions in Type 1 diabetes
ESGCT 27th Annual Congress in collaboration with SETGyc, Barcelona, İspanya, 22 - 25 Ekim 2019, ss.1
1- Lentivirus mediated insulin promoter directed insulin gene expression is effective in suppressing postprandial glucose excursions in Type 1 diabetes
ESGCT 27th Annual Congress in collaboration with SETGyc, Barcelona, İspanya, 22 - 25 Ekim 2019, ss.1
LentiVIP delivery suppresses systemic inflammation which results in beneficial outcome in Type 1 Diabetes
ESGCT 27th Annual Congress in collaboration with SETGyc, Barcelona, İspanya, 22 - 25 Ekim 2019, ss.1
LentiVIP delivery suppresses systemic inflammation which results in beneficial outcome in Type 1 Diabetes
ESGCT 27th Annual Congress in collaboration with SETGyc, Barcelona, İspanya, 22 - 25 Ekim 2019, ss.1
Development of MODY10 diabetic experimental animal model using CRISPR/Cas9 technology for insulin gene transfer studies
European-Society-of-Gene-and-Cell-Therapy (ESCGT) Congress, Berlin, Almanya, 01 Ocak 2017, cilt.28
Development of a gene therapy vector to provide insulin expression from induced pluripotent stem cells
European-Society-of-Gene-and-Cell-Therapy (ESCGT) Congress, Berlin, Almanya, 01 Ocak 2017, cilt.28
A practical method for production and purification of 3rd generation HIV based lentiviral vectors for In vivo applications
European-Society-of-Gene-and-Cell-Therapy (ESCGT) Congress, Berlin, Almanya, 01 Ocak 2017, cilt.28
Generation of a lentiviral vector encoding vasoactive intestinal peptide for type 1 diabetes
European-Society-of-Gene-and-Cell-Therapy (ESCGT) Congress, Berlin, Almanya, 01 Ocak 2017, cilt.28
Multiple low-dose streptozotocin injections induced diabetes in Wistar rats characterised by insulitis and hyperglycaemia useful for gene transfer studies
European-Society-of-Gene-and-Cell-Therapy (ESCGT) Congress, Berlin, Almanya, 01 Ocak 2017, cilt.28
Generation of a beta cell specific insulin gene therapy vector for diabetes
European-Society-of-Gene-and-Cell-Therapy (ESCGT) Congress, Berlin, Almanya, 01 Ocak 2017, cilt.28
Glucagon like peptide-1 as an antidiabetic gene therapy agent inducing transdifferantiation of pancreatic endocrine cells
European-Society-of-Gene-and-Cell-Therapy (ESCGT) Congress, Berlin, Almanya, 01 Ocak 2017, cilt.28
Tip 1 diyabet için vazoaktif intestinal peptidi kodlayan lentiviral vektörün geliştirilmesi.
15. Ulusal Tıbbi Biyoloji ve Genetik Kongresi, Muğla, Türkiye, 26 - 29 Ekim 2017
Diyabet hastalığına karşı kullanılmak üzere beta hücre spesifik gen tedavi vektörünun oluşturulması
15. Ulusal Tıbbi Biyoloji ve Genetik Kongresi, Muğla, Türkiye, 26 - 29 Ekim 2017, ss.1
Diyabet hastalığına karşı kullanılmak üzere beta hücre spesifik gen tedavi vektörünun oluşturulması
15. Ulusal Tıbbi Biyoloji ve Genetik Kongresi, Muğla, Türkiye, 26 Ekim - 29 Kasım 2017, ss.8
3. jenerasyon HIV tabanli lentiviral vektörlerin ın vivo uygulamalar için u¨retimi ve pu¨rifikasyon yöntemlerinin optimizasyonu
15. Ulusal Tıbbi Biyoloji ve Genetik Kongresi, Muğla, Türkiye, 26 - 29 Ekim 2017
İnsulin gen replasman tedavisinde kullanılmak u¨zere CRISPR- Cas9 yöntemiyle MODY10 diyabetik deney hayvan modeli oluşturma
15. Ulusal Tıbbi Biyoloji ve Genetik Kongresi, Muğla, Türkiye, 26 - 29 Ekim 2017, ss.12
3. jenerasyon HIV tabanli lentiviral vektörlerin ın vivo uygulamalar için u¨retimi ve pu¨rifikasyon yöntemlerinin optimizasyonu
15. Ulusal Tıbbi Biyoloji ve Genetik Kongresi, Muğla, Türkiye, 26 - 29 Ekim 2017, ss.10
Tip 1 diyabet için vazoaktif intestinal peptidi kodlayan lentiviral vektörün geliştirilmesi
15. Ulusal Tıbbi Biyoloji ve Genetik Kongresi, Muğla, Türkiye, 26 - 29 Ekim 2017, ss.1
Tip 1 diyabet için vazoaktif intestinal peptidi kodlayan lentiviral vektöru¨n geliştirilmesi.
15. Ulusal Tıbbi Biyoloji ve Genetik Kongresi, Muğla, Türkiye, 26 - 29 Ekim 2017
Diyabet hastalığına karşı kullanılmak u¨zere beta hu¨cre spesifik gen tedavi vektöru¨nu¨n oluşturulması
15. Ulusal Tıbbi Biyoloji ve Genetik Kongresi, Muğla, Türkiye, 26 Ekim - 29 Kasım 2017, ss.8
3. jenerasyon HIV tabanli lentiviral vektörlerin ın vivo uygulamalar için üretimi ve pürifikasyon yöntemlerinin optimizasyonu
15. Ulusal Tıbbi Biyoloji ve Genetik Kongresi, Muğla, Türkiye, 26 - 29 Ekim 2017, ss.10
İnsulin gen replasman tedavisinde kullanılmak üzere CRISPR- Cas9 yöntemiyle MODY10 diyabetik deney hayvan modeli oluşturma
15. Ulusal Tıbbi Biyoloji ve Genetik Kongresi, Muğla, Türkiye, 26 - 29 Ekim 2017, ss.12
Generation of a beta cell specific insulin gene therapy vector for diabetes
ESGCT XXV Anniversary Congress, Berlin, Almanya, 17 Ekim - 20 Kasım 2017, ss.341
Multiple low-dose streptozotocin injections induced diabetes in Wistar rats characterised by insulitis and hyperglycaemia useful for gene transfer studies
ESGCT XXV Anniversary Congress, Berlin, Almanya, 17 - 21 Ekim 2017, ss.113
Generation of a lentiviral vector encoding vasoactive intestinal peptide for type 1 diabetes
European Society of Gene and Cell Therapy (ESGCT) XXV Anniversary Congress, Berlin, Almanya, 17 - 20 Ekim 2017, ss.1
Development of MODY10 diabetic experimental animal model using CRISPR/Cas9 technology for insulin gene transfer studies
ESGCT XXV Anniversary Congress, Berlin, Almanya, 17 - 20 Ekim 2017, ss.112
Development of MODY10 diabetic experimental animal model using CRISPR/Cas9 technology for insulin gene transfer studies
ESGCT XXV Anniversary Congress, Berlin, Almanya, 17 - 20 Ekim 2017, ss.112
Generation of a lentiviral vector encoding vasoactive intestinal peptide for type 1 diabetes
ESGCT XXV Anniversary Congress, Berlin, Almanya, 17 - 20 Ekim 2017, ss.152
Generation of a beta cell specific insulin gene therapy vector for diabetes
ESGCT XXV Anniversary Congress, Berlin, Almanya, 17 Ekim - 20 Kasım 2017, ss.341
Generation of a beta cell specific insulin gene therapy vector for diabetes", ESGCT XXV Anniversary Congress
European Society of Gene and Cell Therapy (ESGCT) XXV Anniversary Congress, Berlin, Almanya, 17 - 20 Ekim 2017, ss.1
Generation of a lentiviral vector encoding vasoactive intestinal peptide for type 1 diabetes
ESGCT XXV Anniversary Congress, Berlin, Almanya, 17 - 20 Ekim 2017, ss.152
A practical method for production and purification of 3rd generation HIV based lentiviral vectors for In vivo applications
ESGCT XXV Anniversary Congress, Berlin, Almanya, 17 - 20 Ekim 2017, ss.176
Multiple low-dose streptozotocin injections induced diabetes in Wistar rats characterised by insulitis and hyperglycaemia useful for gene transfer studies
ESGCT XXV Anniversary Congress, Berlin, Almanya, 17 - 21 Ekim 2017, ss.113
Multiple low-dose streptozotocin injections induced diabetes in Wistar rats characterised by insulitis and hyperglycaemia useful for gene transfer studies
European Society of Gene and Cell Therapy (ESGCT) ESGCT XXV Anniversary Congress, Berlin, Almanya, 17 - 21 Ekim 2017, ss.1
A practical method for production and purification of 3rd generation HIV based lentiviral vectors for In vivo applications
ESGCT XXV Anniversary Congress, Berlin, Almanya, 17 - 20 Ekim 2017, ss.176
Diyabet Hastalığına karşı geliştirilen gen tedavi stratejilerinde kullanılmak üzere tip 1 diyabet hayvan modelinin oluşturulması
53. Ulusal Diyabet Kongresi, Girne, Kıbrıs (Kktc), 19 - 23 Nisan 2017, ss.251
Diyabet hastalığına karşı geliştirilen gen tedavi stratejilerinde kullanılmak üzere Tip 1 Diyabet hayvan modelinin oluşturulması
53. Ulusal Diyabet Kongresi, Girne, Kıbrıs (Kktc), 19 - 23 Nisan 2017, ss.1
İnkretin gen nakli diyabetik deneklerde insülin direncini kırıp glukoz toleransını geliştirerek beta hücre rejenerasyonu sağlar
53. Ulusal Diyabet Kongresi, Girne, Kıbrıs (Kktc), 19 - 23 Nisan 2017, ss.250
Diyabette insülin gen tedavi stratejileri
53. Ulusal Diyabet Kongresi, Girne, Türkiye, 19 - 23 Nisan 2017, ss.117-118
Diyabet tedavisinde in vivo gen nakil uygulamalarına uygun ölçekte ve kalitede lentiviral vektör üretimi
53. Ulusal Diyabet Kongresi., Girne, Türkiye, 19 - 23 Nisan 2017, ss.6
İnkretin gen nakli diyabetik deneklerde insülin direncini kırıp glukoz toleransını geliştirerek beta hücre rejenerasyonu sağlar
53. Ulusal Diyabet Kongresi, Girne, Türkiye, 19 - 23 Nisan 2017, ss.10
Diyabet hastalığına karşı geliştirilen gen tedavi stratejilerinde kullanılmak üzere Tip 1 Diyabet hayvan modelinin oluşturulması
53. Ulusal Diyabet Kongresi, Girne, Türkiye, 19 - 23 Nisan 2017, ss.11
Diyabet Hastalığına karşı geliştirilen gen tedavi stratejilerinde kullanılmak üzere tip 1 diyabet hayvan modelinin oluşturulması
53. Ulusal Diyabet Kongresi, Girne, Kıbrıs (Kktc), 19 - 23 Nisan 2017, ss.251
Diyabet hastalığına karşı geliştirilen gen tedavi stratejilerinde kullanılmak üzere Tip 1 Diyabet hayvan modelinin oluşturulması
53. Ulusal Diyabet Kongresi, Girne, Türkiye, 19 - 23 Nisan 2017, ss.11
Glucagon like peptide-1 gene delivery increases beta cell replication and neogenesis in Type 2 Diabetic Obese Sprague Dawley Rats
Conference on Changing the Face of Modern Medicine - Stem Cells and Gene Therapy, Florence, İtalya, 18 - 21 Ekim 2016, cilt.27
Generation of a lentiviral vector encoding human insulin for diabetes treatment
Conference on Changing the Face of Modern Medicine - Stem Cells and Gene Therapy, Florence, İtalya, 18 - 21 Ekim 2016, cilt.27
Novel approaches for insulin mediated gene delivery in diabetes treatment
Conference on Changing the Face of Modern Medicine - Stem Cells and Gene Therapy, Florence, İtalya, 18 - 21 Ekim 2016, cilt.27
Glucagon like peptide-1 gene delivery increases beta cell replication and neogenesis in Type 2 Diabetic Obese Sprague Dawley Rats
Conference on Changing the Face of Modern Medicine - Stem Cells and Gene Therapy., Floransa, İtalya, 18 - 21 Ekim 2016, cilt.27, sa.11
Glucagon like peptide-1 gene delivery increases beta cell replication and neogenesis in Type 2 Diabetic Obese Sprague Dawley Rats
Conference on Changing the Face of Modern Medicine - Stem Cells and Gene Therapy., Floransa, İtalya, 18 - 21 Ekim 2016, cilt.27, sa.11
Pankreatik beta hücre hedefli HİV tabanlı insülin gen tedavi vektörünün oluşturulması
Uluslararası Katılımlı 12. Ulusal Tıbbi Genetik Kongresi, İzmir, Türkiye, 5 - 09 Ekim 2016, cilt.2, ss.206
Diyabet Tedavisinde inkretin tabanlı gen tedavi stratejileri.
Uluslararası Katılımlı 12. Ulusal Tıbbi Genetik Kongresi, İzmir, Türkiye, 5 - 09 Ekim 2016, cilt.2, ss.67-68
EF-1 promotoru kontrolünde insulin gen ekspresyonu yapan HİV tabanlı lentiviral gen tedavi vektörünün oluşturulması
Uluslararası Katılımlı 12. Ulusal Tıbbi Genetik Kongresi, İzmir, Türkiye, 5 - 09 Ekim 2016, cilt.2, ss.200
Pankreatik beta hücre hedefli HİV tabanlı insülin gen tedavi vektörünün oluşturulması
Uluslararası Katılımlı 12. Ulusal Tıbbi Genetik Kongresi, İzmir, Türkiye, 5 - 09 Ekim 2016, cilt.2, ss.206
EF-1 promotoru kontrolünde insulin gen ekspresyonu yapan HİV tabanlı lentiviral gen tedavi vektörünün oluşturulması
Uluslararası Katılımlı 12. Ulusal Tıbbi Genetik Kongresi, İzmir, Türkiye, 5 - 09 Ekim 2016, cilt.2, ss.200
EF-1 promotoru kontrolünde insulin gen ekspresyonu yapan HİV tabanlı lentiviral gen tedavi vektörünün oluşturulması
Uluslararası Katılımlı 12. Ulusal Tıbbi Genetik Kongresi, İzmir, Türkiye, 5 - 09 Ekim 2016, cilt.2, ss.200
Pankreatik beta hücre hedefli HİV tabanlı insülin gen tedavi vektörünün oluşturulması
Uluslararası Katılımlı 12. Ulusal Tıbbi Genetik Kongresi, İzmir, Türkiye, 5 - 09 Ekim 2016, cilt.2, ss.206
Pankreatik beta hücre hedefli HİV tabanlı insülin gen tedavi vektörünün oluşturulması
Uluslararası Katılımlı 12. Ulusal Tıbbi Genetik Kongresi, İzmir, Türkiye, 5 - 09 Ekim 2016, cilt.2, ss.206
EF-1 promotoru kontrolünde insulin gen ekspresyonu yapan HİV tabanlı lentiviral gen tedavi vektörünün oluşturulması
Uluslararası Katılımlı 12. Ulusal Tıbbi Genetik Kongresi, İzmir, Türkiye, 5 - 09 Ekim 2016, cilt.2, ss.200
3. Jenerasyon Lentivirus aracılı Vazoaktif İntestinal Peptid gen naklinin obezite bağımlı Tip 2 Diyabet deney hayvan modelinde terapötik etkinliği
14. Ulusal Tıbbi Biyoloji ve Genetik Kongresi, Muğla, Türkiye, 27 - 30 Ekim 2015
Vasoactive intestinal peptide gene delivery for diabetes treatment
Molecular Biologu and Genetics Congress, İstanbul, Türkiye, 2 - 04 Ekim 2015, ss.10
Vasoactive intestinal peptide gene delivery for diabetes treatment
Molecular Biologu and Genetics Congress, İstanbul, Türkiye, 2 - 04 Ekim 2015, ss.10
Obese and diabetic sprague dawley rats exhibited reduced GLP-1 expression in pancreatic islets of Langerhans
Collaborative Congress of the European-Society-of-Gene-and-Cell-Therapy (ESGCT) and Finnish-Society-of-Gene-Therapy (FSGT), Helsinki, Finlandiya, 17 - 20 Eylül 2015, cilt.26
Therapeutic outcomes of an HIV-based lentivirus mediated Glucagon-like peptide-1 gene delivery for diabetes treatment
Collaborative Congress of the European-Society-of-Gene-and-Cell-Therapy (ESGCT) and Finnish-Society-of-Gene-Therapy (FSGT), Helsinki, Finlandiya, 17 - 20 Eylül 2015, cilt.26
In vivo distribution of HIV based 3rd generation of lentiviral vectors used in gene therapy in DOI animal model of type 2 diabetes
Collaborative Congress of the European-Society-of-Gene-and-Cell-Therapy (ESGCT) and Finnish-Society-of-Gene-Therapy (FSGT), Helsinki, Finlandiya, 17 - 20 Eylül 2015, cilt.26
Obese and diabetic sprague dawley rats exhibited reduced GLP-1 expression in pancreatic islets of Langerhans
ESGCT and FSGCT Collaborative Congress,2015, Helsinki, Finlandiya, 17 - 20 Eylül 2015
In vivo distribution of HIV based 3rd generation of lentiviral vectors used in gene therapy in DOI animal model of type 2 diabetes
ESGCT and FSGCT Collaborative Congress,2015, Helsinki, Finlandiya, 17 - 20 Eylül 2015
Obese and diabetic sprague dawley rats exhibited reduced GLP-1 expression in pancreatic islets of Langerhans
ESGCT and FSGCT Collaborative Congress,2015, Helsinki, Finlandiya, 17 - 20 Eylül 2015
Therapeutic outcomes of an HIV-based lentivirus mediated Glucagon-like peptide-1 gene delivery for diabetes treatment
ESGCT and FSGCT Collaborative Congress, Helsinki, Finlandiya, 17 - 20 Eylül 2015
In vivo distribution of HIV based 3rd generation of lentiviral vectors used in gene therapy in DOI animal model of type 2 diabetes
ESGCT and FSGCT Collaborative Congress,2015, Helsinki, Finlandiya, 17 - 20 Eylül 2015
In vivo distribution of HIV based 3rd generation of lentiviral vectors used in gene therapy in DOI animal model of type 2 diabetes
ESGCT and FSGCT Collaborative Congress,2015, Helsinki, Finlandiya, 17 - 20 Eylül 2015
In vivo distribution of HIV based 3rd generation of lentiviral vectors used in gene therapy in DOI animal model of type 2 diabetes
ESGCT and FSGCT Collaborative Congress,2015, Helsinki, Finlandiya, 17 - 20 Eylül 2015
Therapeutic outcomes of an HIV-based lentivirus mediated Glucagon-like peptide-1 gene delivery for diabetes treatment
ESGCT and FSGCT Collaborative Congress,2015, Helsinki, Finlandiya, 17 - 20 Eylül 2015
Diyabet tedavisi için insan Glukagon Benzeri Peptid-1 kodlayan lentiviral vektörlerin üretimi
51. Ulusal Diyabet Kongresi, Antalya, Türkiye, 22 - 26 Nisan 2015
Gen tedavisinde kullanılan lentivlral vektörlerin in vivo dağılımlarının Tip 2 Diyabet hayvan modelinde belirlenmesi
51. Ulusal Diyabet Kongresi, Antalya, Türkiye, 22 - 26 Nisan 2015, ss.146-147
Diyabet tedavisi için insan Glukagon Benzeri Peptid-1 kodlayan lentiviral vektörlerin üretimi
51. Ulusal Diyabet Kongresi, Antalya, Türkiye, 22 - 26 Nisan 2015
HİV tabanlı Lentivirus aracılı Vazoaktif İntestinal Peptid gen nakli obez farelerde insulin direncini kırıp glukoz toleransı geliştirerek STZ indüklü diyabet gelişimini durdurdu
51. Ulusal Diyabet Kongresi, Antalya, Türkiye, 22 - 26 Nisan 2015
Diyet bağımlı obez Sprague Dawley sıçanlarda STZ ile diyabet indüksiyonu pankreatik adacıklarda inkretin hormonu (GLP-1) sentezini azaltır
51. Ulusal Diyabet Kongresi, Antalya, Türkiye, 22 - 26 Nisan 2015, ss.146
Diyet bağımlı obez Sprague Dawley sıçanlarda STZ ile diyabet indüksiyonu pankreatik adacıklarda inkretin hormonu (GLP-1) sentezini azaltır
51. Ulusal Diyabet Kongresi, Antalya, Türkiye, 22 - 26 Nisan 2015, ss.146
Gen tedavisinde kullanılan lentivlral vektörlerin in vivo dağılımlarının Tip 2 Diyabet hayvan modelinde belirlenmesi
51. Ulusal Diyabet Kongresi, Antalya, Türkiye, 22 - 26 Nisan 2015, ss.146-147
Gen tedavisinde kullanılan lentivlral vektörlerin in vivo dağılımlarının Tip 2 Diyabet hayvan modelinde belirlenmesi
51. Ulusal Diyabet Kongresi, Antalya, Türkiye, 22 - 26 Nisan 2015, ss.146-147
Gen tedavisinde kullanılan lentivlral vektörlerin in vivo dağılımlarının Tip 2 Diyabet hayvan modelinde belirlenmesi
51. Ulusal Diyabet Kongresi, Antalya, Türkiye, 22 - 26 Nisan 2015, ss.146-147
Construction of A lentiviral Vector Encoding Human Vasoactive Intestinal Peptide for Diabetes Treatment
EMBO Workshop, Evry, Fransa, 30 Mart - 04 Nisan 2015, ss.185
Construction of A lentiviral Vector Encoding Human Vasoactive Intestinal Peptide for Diabetes Treatment
EMBO Workshop, Evry, Fransa, 30 Mart - 04 Nisan 2015, ss.185
Construction of A lentiviral Vector Encoding Human Vasoactive Intestinal Peptide for Diabetes Treatment
EMBO Workshop, Evry, Fransa, 30 Mart - 04 Nisan 2015, ss.185
Construction of A lentiviral Vector Encoding Human Vasoactive Intestinal Peptide for Diabetes Treatment
EMBO Workshop, Evry, Fransa, 30 Mart - 04 Nisan 2015, ss.185
Comparative efficacy of diet induced obesity in C57BL/6J versus Balb/C mice for gene therapy applications
ESGCT and NVGCT Collaborative Congress, The Hague, Hollanda, 23 - 26 Ekim 2014, cilt.25
Up-regulation of Glucagon Like Peptide-1 Expression in pancreases of C57BL6J Mice with Diabetes
ESGCT and NVGCT Collaborative Congress, The Hague, Hollanda, 23 - 26 Ekim 2014, cilt.25
Induction of Diet Induced Obesity in Sprague Dawley Rats as a Model for Type 2 Diabetes
ESGCT and NVGCT Collaborative Congress, The Hague, Hollanda, 23 - 26 Ekim 2014, cilt.25
Generation of A Lentiviral Vector Encoding Human Glucagon Like Peptide-1 (GLP-1) for Diabetes Treatment
ESGCT and NVGCT Collaborative Congress, The Hague, Hollanda, 23 - 26 Ekim 2014, cilt.25
Induction of Diet İnduced Obesity in Sprague Dawley Rats as a Model of Type 2 Diabetes
The XXII. Annual ESGCT Congress in collaboration with the NCGCT, Hague, Hollanda, 23 - 26 Ekim 2014
Comperative efficacy of Diet İnduced Obesity in c57bl/6j versus Balb/C mice for gene Threapy applications
The XXII. Annual ESGCT Congress in collaboration with the NCGCT, Hague, Hollanda, 23 - 26 Ekim 2014
Generation of A Lentiviral Vector Encoding Human Glucagon Like Peptide-1 (GLP-1) for Diabetes Treatment
ESGCT AND NVGCT COLLABORATIVE CONGRESS, 2014, The Hauge, Amsterdam, Hollanda, 23 - 26 Ekim 2014, cilt.25, sa.11, ss.87-88
Construction of A Lentiviral Vector Encoding Human Vasoactive Intestinal Peptide for Diabetes Treatment
Human Gene TherapyESGCT and NVGCT Collaborative Congress, The Hague, Hollanda, 23 - 26 Ekim 2014, ss.123
Up Regulation of Glucagon Like Peptide-1 Expression in Pancreases of C57BL6j Mice with Diabetes
The XXII. Annual ESGCT Congress in collaboration with the NCGCT, Hague, Hollanda, 23 - 26 Ekim 2014
Construction of A Lentiviral Vector Encoding Human Vasoactive Intestinal Peptide for Diabetes Treatment
Human Gene TherapyESGCT and NVGCT Collaborative Congress, The Hague, Hollanda, 23 - 26 Ekim 2014, ss.123
Construction of A Lentiviral Vector Encoding Human Vasoactive Intestinal Peptide for Diabetes Treatment
Human Gene TherapyESGCT and NVGCT Collaborative Congress, The Hague, Hollanda, 23 - 26 Ekim 2014, ss.123
Induction of Diet İnduced Obesity in Sprague Dawley Rats as a Model of Type 2 Diabetes
The XXII. Annual ESGCT Congress in collaboration with the NCGCT, Hague, Hollanda, 23 - 26 Ekim 2014
Comperative efficacy of Diet İnduced Obesity in c57bl/6j versus Balb/C mice for gene Threapy applications
The XXII. Annual ESGCT Congress in collaboration with the NCGCT, Hague, Hollanda, 23 - 26 Ekim 2014
Construction of A Lentiviral Vector Encoding Human Vasoactive Intestinal Peptide for Diabetes Treatment
Human Gene TherapyESGCT and NVGCT Collaborative Congress, The Hague, Hollanda, 23 - 26 Ekim 2014, ss.123
Generation of A Lentiviral Vector Encoding Human Glucagon Like Peptide-1 (GLP-1) for Diabetes Treatment
ESGCT AND NVGCT COLLABORATIVE CONGRESS, 2014, The Hauge, Amsterdam, Hollanda, 23 - 26 Ekim 2014, cilt.25, sa.11, ss.87-88
Up Regulation of Glukagon Like Peptide-1 Expression in Pancreases of C57BL6j Mice with Diabetes
The XXII. Annual ESGCT Congress in collaboration with the NCGCT, Hague, Hollanda, 23 - 26 Ekim 2014
Therapeutic efficacy of an HIV-Based Lentivirus Mediated Vasoactive İntestinal Peptide Gene Delivery for Diabetes
The XXII. Annual ESGCT Congress in collaboration with the NCGCT, Hague, Hollanda, 23 - 26 Ekim 2014
Generation of A Lentiviral Vector Encoding Human Glucagon Like Peptide-1 (GLP-1) for Diabetes Treatment
ESGCT AND NVGCT COLLABORATIVE CONGRESS, 2014, The Hauge, Amsterdam, Hollanda, 23 - 26 Ekim 2014, cilt.25, sa.11, ss.87-88
Comperative efficacy of Diet İnduced Obesity in c57bl/6j versus Balb/C mice for gene Threapy applications
The XXII. Annual ESGCT Congress in collaboration with the NCGCT, Hague, Hollanda, 23 - 26 Ekim 2014
Up Regulation of Glukagon Like Peptide-1 Expression in Pancreases of C57BL6j Mice with Diabetes
The XXII. Annual ESGCT Congress in collaboration with the NCGCT, Hague, Hollanda, 23 - 26 Ekim 2014
Generation of A Lentiviral Vector Encoding Human Glucagon Like Peptide-1 (GLP-1) for Diabetes Treatment
ESGCT AND NVGCT COLLABORATIVE CONGRESS, 2014, The Hauge, Amsterdam, Hollanda, 23 - 26 Ekim 2014, cilt.25, sa.11, ss.87-88
Therapeutic efficacy of an HIV-Based Lentivirus Mediated Vasoactive İntestinal Peptide Gene Delivery for Diabetes
The XXII. Annual ESGCT Congress in collaboration with the NCGCT, Hague, Hollanda, 23 - 26 Ekim 2014
Therapeutic efficacy of an HIV-Based Lentivirus Mediated Vasoactive İntestinal Peptide Gene Delivery for Diabetes
The XXII. Annual ESGCT Congress in collaboration with the NCGCT, Hague, Hollanda, 23 - 26 Ekim 2014
Constitution of Pre-diabetic State in C57BL6J Mice Versus Sprague Dawley Rats
American Diabetes Association, San Francisco, Amerika Birleşik Devletleri, 14 - 17 Haziran 2014, ss.659
Constitution of Pre-diabetic State in C57BL6J Mice Versus Sprague Dawley Rats
American Diabetes Association, San Francisco, Amerika Birleşik Devletleri, 14 - 17 Haziran 2014, ss.659
Constitution of Pre-diabetic State in C57BL6J Mice Versus Sprague Dawley Rats
American Diabetes Association, San Francisco, Amerika Birleşik Devletleri, 14 - 17 Haziran 2014, ss.659
Constitution of Pre-diabetic State in C57BL6J Mice Versus Sprague Dawley Rats
American Diabetes Association, San Francisco, Amerika Birleşik Devletleri, 14 - 17 Haziran 2014, ss.659
Constitution of Pre-diabetic State in C57BL6J Mice Versus Sprague Dawley Rats
American Diabetes Association, San Francisco, Amerika Birleşik Devletleri, 13 - 17 Haziran 2014, cilt.63
Constitution of Pre-diabetic State in C57BL6J Mice Versus Sprague Dawley Rats
American Diabetes Association, San Francisco, Amerika Birleşik Devletleri, 13 - 17 Haziran 2014, cilt.63
Constitution of Pre-diabetic State in C57BL6J Mice Versus Sprague Dawley Rats
American Diabetes Association, San Francisco, Amerika Birleşik Devletleri, 13 - 17 Haziran 2014, cilt.63
Constitution of Pre-diabetic State in C57BL6J Mice Versus Sprague Dawley Rats
American Diabetes Association, San Francisco, Amerika Birleşik Devletleri, 13 - 17 Haziran 2014, cilt.63
Restoration of Pancreatic Beta Cell Mass and Function by GLP-1 Gene Delivery for Diabetes
Beta Cells in Health and Disease, Kocaeli, Türkiye, 21 - 23 Mayıs 2014, ss.1
Diyabet hastalığına karşı geliştirilen insan vazoaktif intestinal peptid kodlayan HİV tabanlı gen transfer vektörlerinin yapımı ve testi
50. Ulusal Diyabet Kongresi, Antalya, Türkiye, 23 - 27 Nisan 2014, ss.12
C57BL6J FARELERDE DİYABET İNDÜKSİYONU PANKREAS KÖKENLİ GLP-1 SENTEZİNİ ARTTIRDI
50. Ulusal Diyabet Kongresi, Antalya, Türkiye, 23 - 27 Nisan 2014, ss.166
Diyabet tedavisinde inkretin tabanlı gen transfer stratejilerinin yeri
50. Ulusal Diyabet Kongresi, Antalya, Türkiye, 23 - 27 Nisan 2014
C57BL6J FARELERDE DİYABET İNDÜKSİYONU PANKREAS KÖKENLİ GLP-1 SENTEZİNİ ARTTIRDI
50. Ulusal Diyabet Kongresi, Antalya, Türkiye, 23 - 27 Nisan 2014, ss.166
C57BL6J FARELERDE DİYABET İNDÜKSİYONU PANKREAS KÖKENLİ GLP-1 SENTEZİNİ ARTTIRDI
50. Ulusal Diyabet Kongresi, Antalya, Türkiye, 23 - 27 Nisan 2014, ss.166
Diyabet hastalığına karşı geliştirilen insan vazoaktif intestinal peptid kodlayan HİV tabanlı gen transfer vektörlerinin yapımı ve testi
50. Ulusal Diyabet Kongresi, Antalya, Türkiye, 23 - 27 Nisan 2014, ss.12
C57BL6J FARELERDE DİYABET İNDÜKSİYONU PANKREAS KÖKENLİ GLP-1 SENTEZİNİ ARTTIRDI
50. Ulusal Diyabet Kongresi, Antalya, Türkiye, 23 - 27 Nisan 2014, ss.166
Diyabet hastalığına karşı geliştirilen insan vazoaktif intestinal peptid kodlayan HİV tabanlı gen transfer vektörlerinin yapımı ve testi
50. Ulusal Diyabet Kongresi, Antalya, Türkiye, 23 - 27 Nisan 2014, ss.12
Diyabet hastalığına karşı geliştirilen insan vazoaktif intestinal peptid kodlayan HİV tabanlı gen transfer vektörlerinin yapımı ve testi
50. Ulusal Diyabet Kongresi, Antalya, Türkiye, 23 - 27 Nisan 2014, ss.12
GLP-1 and GLP-1-receptor expression profiles in pancreatic islets of Diet Induced Obese (DIO) Mice
Collaborative Congress of the European-Society-for-Gene-and-Cell-Therapy and the Spanish-Society-for-Gene-and-Cell-Therapy, Madrid, İspanya, 25 - 28 Ekim 2013, cilt.24
Pancreatic expression profiles of vasoactive intestinal peptide and its receptors in mouse model of type 2 diabetes
Collaborative Congress of the European-Society-for-Gene-and-Cell-Therapy and the Spanish Society for Gene and Cell Therapy, Madrid, İspanya, 25 - 28 Ekim 2013, cilt.24, sa.12, ss.138
Pancreatic expression profiles of vasoactive intestinal peptide and its receptors in mouse model of type 2 diabetes
Collaborative Congress of the European-Society-for-Gene-and-Cell-Therapy and the Spanish Society for Gene and Cell Therapy, Madrid, İspanya, 25 - 28 Ekim 2013, cilt.24, sa.12, ss.138
Pancreatic expression profiles of vasoactive intestinal peptide and its receptors in mouse model of type 2 diabetes
Collaborative Congress of the European-Society-for-Gene-and-Cell-Therapy and the Spanish Society for Gene and Cell Therapy, Madrid, İspanya, 25 - 28 Ekim 2013, cilt.24, sa.12, ss.138
Pancreatic expression profiles of vasoactive intestinal peptide and its receptors in mouse model of type 2 diabetes
Collaborative Congress of the European-Society-for-Gene-and-Cell-Therapy and the Spanish Society for Gene and Cell Therapy, Madrid, İspanya, 25 - 28 Ekim 2013, cilt.24, sa.12, ss.138
Downregulation of Vasoactive Intestinal Peptide Expression in Type 2 Diabetes
Congress of American Diabetes Association, Chicago, Amerika Birleşik Devletleri, 21 - 25 Haziran 2013, cilt.62, ss.2258
Downregulation of Vasoactive Intestinal Peptide Expression in Type 2 Diabetes
Congress of American Diabetes Association, Chicago, Amerika Birleşik Devletleri, 21 - 25 Haziran 2013, cilt.62, ss.2258
Downregulation of Vasoactive Intestinal Peptide Expression in Type 2 Diabetes
Congress of American Diabetes Association, Chicago, Amerika Birleşik Devletleri, 21 - 25 Haziran 2013, cilt.62, ss.2258
Tip 2 diyabet deney hayvan modelinde diyabet induksiyonu adaciklarda vazoaktif intestinal peptid azalimiyla korelasyon gosterdi
49. Ulusal Diyabet Kongresi, Antalya, Türkiye, 17 - 21 Nisan 2013, ss.20
Diyabette Vazoaktif Intestinal Peptidin terapotik rolü
49. Ulusal Diyabet Kongresi, Antalya, Türkiye, 17 - 21 Nisan 2013, ss.12
Tip 2 diyabet deney hayvan modelinde diyabet induksiyonu adaciklarda vazoaktif intestinal peptid azalimiyla korelasyon gosterdi
49. Ulusal Diyabet Kongresi, Antalya, Türkiye, 17 - 21 Nisan 2013, ss.20
Tip 2 diyabet deney hayvan modelinde diyabet induksiyonu adaciklarda vazoaktif intestinal peptid azalimiyla korelasyon gosterdi
49. Ulusal Diyabet Kongresi, Antalya, Türkiye, 17 - 21 Nisan 2013, ss.20
Tip 2 diyabet deney hayvan modelinde diyabet induksiyonu adaciklarda vazoaktif intestinal peptid azalimiyla korelasyon gosterdi
49. Ulusal Diyabet Kongresi, Antalya, Türkiye, 17 - 21 Nisan 2013, ss.20
Diyabette Vazoaktif Intestinal Peptidin terapotik rolü
49. Ulusal Diyabet Kongresi, Antalya, Türkiye, 17 - 21 Nisan 2013, ss.12
Generation of a cost effective and a practical animal model for Type 2 Diabetes
Collaborative Congress of the European Society of Gene and Cell Therapy/French Society of Cell and Gene Therapy, Versailles, Fransa, 25 - 29 Ekim 2012, cilt.23, sa.10, ss.78-79
Generation of a cost effective and a practical animal model for Type 2 Diabetes
Collaborative Congress of the European Society of Gene and Cell Therapy/French Society of Cell and Gene Therapy, Versailles, Fransa, 25 - 29 Ekim 2012, cilt.23, sa.10, ss.78-79
Generation of a cost effective and a practical animal model for Type 2 Diabetes
Collaborative Congress of the European Society of Gene and Cell Therapy/French Society of Cell and Gene Therapy, Versailles, Fransa, 25 - 29 Ekim 2012, cilt.23, sa.10, ss.78-79
Potential Therapeutic Role of Vasoactive Intestinal Peptide in Diabetes
Collaborative Congress of the European-Society-of-Gene-and-Cell-Therapy/French-Society-of-Cell-and-Gene-Therapy, Versailles, Fransa, 25 - 29 Ekim 2012, cilt.23
Multiple Myeloma Patients Display Decreased Death Ligand Expression on T Lymphocytes
Collaborative Congress of the European-Society-of-Gene-and-Cell-Therapy/French-Society-of-Cell-and-Gene-Therapy, Versailles, Fransa, 25 - 29 Ekim 2012, cilt.23
Generation of a cost effective and a practical animal model for Type 2 Diabetes
Collaborative Congress of the European-Society-of-Gene-and-Cell-Therapy/French-Society-of-Cell-and-Gene-Therapy, Versailles, Fransa, 25 - 29 Ekim 2012, cilt.23
Pancreatic acinar cells respond differentially to diabetic agents Streptozotocin and Cyclophosphamide
Collaborative Congress of the European-Society-of-Gene-and-Cell-Therapy/French-Society-of-Cell-and-Gene-Therapy, Versailles, Fransa, 25 - 29 Ekim 2012, cilt.23
The efficacy of insulin gene therapy in autoimmune diabetes
Molecular Immunology & Immunogenetics Congress, Antalya, Türkiye, 27 - 29 Nisan 2012, ss.49-50
Rexin G, the first and the only targetted gene delivery vehicle developed to seek out and destroy metastatic cancer cell to date
XII Ulusal Tibbi Biyoloji ve Genetik Kongresi, Antalya, Türkiye, 27 - 30 Ekim 2011, ss.15
NOD farelerde streptozotosin veye siklofosfamid ile hizlandirilmis Tip 1 Diyabet gelisim surecinde pankreatik asinar hucrelerde farkli TRAIL ligand ve reseptor paternleri
XII Ulusal Tibbi Biyoloji ve Genetik Kongresi, Antalya, Türkiye, 27 - 30 Ekim 2011, ss.187
Rexin G, the first and the only targetted gene delivery vehicle developed to seek out and destroy metastatic cancer cell to date
XII Ulusal Tibbi Biyoloji ve Genetik Kongresi, Antalya, Türkiye, 27 - 30 Ekim 2011, ss.15
NOD farelerde streptozotosin veye siklofosfamid ile hizlandirilmis Tip 1 Diyabet gelisim surecinde pankreatik asinar hucrelerde farkli TRAIL ligand ve reseptor paternleri
XII Ulusal Tibbi Biyoloji ve Genetik Kongresi, Antalya, Türkiye, 27 - 30 Ekim 2011, ss.187
Tip 1 Diyabette gen ve hucre tedavisinin yeri
Turkiye Endokrinoloji ve Metabolizma Hastaliklari Kongresi, Antalya, Türkiye, 12 - 16 Ekim 2011, ss.33
Clinical genetic significance of TRAIL and TRAIL receptors in patients with head and neck cancer
9th National Medical Genetics Congress, İstanbul, Türkiye, 1 - 05 Aralık 2010, ss.59
“In Vivo Fluorescence Tracing Of Xenogeneic Islet Graft Survival In Type 1 Diabetes
9th National Congress of Medical Genetics, İstanbul, Türkiye, 1 - 05 Aralık 2010, cilt.0, sa.0, ss.1-2
Clinical genetic significance of TRAIL and TRAIL receptors in patients with head and neck cancer
9th National Medical Genetics Congress, İstanbul, Türkiye, 1 - 05 Aralık 2010, ss.59
In vivo fluorescence tracing of xenogeneic islet graft survival in Type 1 Diabetes
9th National Medical Genetics Congress, İstanbul, Türkiye, 1 - 05 Aralık 2010, ss.129
Spontaneous type 1 diabetes in NOD mice is related to an increase in DcR1 expression
18th Annual Congress of the European-Society-of-Gene-and-Cell-Therapy, Milan, İtalya, 22 - 25 Ekim 2010, cilt.21, ss.1447-1448
The importance of sTRAIL in patients with rheumatoid arthritis
18th Annual Congress of the European-Society-of-Gene-and-Cell-Therapy, Milan, İtalya, 22 - 25 Ekim 2010, cilt.21, ss.1461
Trail profile of synoviocytes and peripheral blood lymphocytes of rheumatoid arthritis patients
18th Annual Congress of the European-Society-of-Gene-and-Cell-Therapy, Milan, İtalya, 22 - 25 Ekim 2010, cilt.21, ss.1448-1449
Distinctive expression profiles of trail and trail receptors in patients with endometrial carcinoma
18th Annual Congress of the European-Society-of-Gene-and-Cell-Therapy, Milan, İtalya, 22 - 25 Ekim 2010, cilt.21, ss.1462
Endometrial hyperplasia features distinctive trail and trail receptor expression profiles
18th Annual Congress of the European-Society-of-Gene-and-Cell-Therapy, Milan, İtalya, 22 - 25 Ekim 2010, cilt.21, ss.1462-1463
The outcome of trail presentation on T cells in patients with multiple myeloma
18th Annual Congress of the European-Society-of-Gene-and-Cell-Therapy, Milan, İtalya, 22 - 25 Ekim 2010, cilt.21, ss.1462
TRAIL expression significantly decreases in CY-accelerated type 1 diabetes in NOD mice
18th Annual Congress of the European-Society-of-Gene-and-Cell-Therapy, Milan, İtalya, 22 - 25 Ekim 2010, cilt.21, ss.1453-1454
STZ administration leads to a significant rise in TRAIL and DcR1 levels in Non-Obese Diabetic (NOD)
18th Annual Congress of the European-Society-of-Gene-and-Cell-Therapy, Milan, İtalya, 22 - 25 Ekim 2010, cilt.21, ss.1453
In vivo fluorescence imaging of xenogeneic islet graft survival
18th Annual Congress of the European-Society-of-Gene-and-Cell-Therapy, Milan, İtalya, 22 - 25 Ekim 2010, cilt.21, ss.1451
Non-obese diabetic (NOD) farelerde streptozotosin veya siklofosfamid ile indüklenen diyabette T1D’in moleküler patogenezinin aydınlatılmasına yönelik bulgular
46. Ulusal Diyabet Kongresi, Antalya, Türkiye, 12 - 16 Mayıs 2010, ss.6
Non-obese diabetic (NOD) farelerde streptozotosin veya siklofosfamid ile indüklenen diyabette T1D’in moleküler patogenezinin aydınlatılmasına yönelik bulgular
46. Ulusal Diyabet Kongresi, Antalya, Türkiye, 12 - 16 Mayıs 2010, ss.6
TRAIL death receptor-4 and decoy receptors expression on CD8+T cells correlate with the disease severity in rheumatoid arthritis patients p.149, Nov 21-25, 2009, 2009 Hannover, Germany. Human Gene Therapy 2009; 20 (11): 1471-1471
Combined Meeting of the 17th European-Society-of-Gene-and-Cell-Therapy/16th German-Society-for-Gene-Therapy/4th German-Society-for-Stem-Cell-Research,, Hannover, Almanya, 21 - 25 Kasım 2009, cilt.20, ss.1471
Adenovirus mediated TRAIL gene therapy approach provides sustained insulin expression in STZ-induced diabetic rats
17th Annual Congress of the European Society of Gene & Cell Therapy, Hannover, Almanya, 21 - 25 Kasım 2009, ss.1471-1472
Adenovirus mediated TRAIL gene therapy approach provides sustained insulin expression in STZ-induced diabetic rats
17th Annual Congress of the European Society of Gene & Cell Therapy, Hannover, Almanya, 21 - 25 Kasım 2009, ss.1471-1472
Tracing of the fate of allogeneic islet grafts via CCD camera
Combined Meeting of the 17th European-Society-of-Gene-and-Cell-Therapy/16th German-Society-for-Gene-Therapy/4th German-Society-for-Stem-Cell-Research, Hannover, Almanya, 21 - 25 Kasım 2009, cilt.20, ss.1479
Diagnostic significance of serum sTRAIL in rheumatoid arthritis
Combined Meeting of the 17th European-Society-of-Gene-and-Cell-Therapy/16th German-Society-for-Gene-Therapy/4th German-Society-for-Stem-Cell-Research, Hannover, Almanya, 21 - 25 Kasım 2009, cilt.20, ss.1494
Prospective cell and gene therapy approaches designed to extend islet graft survival in patients with type 1 diabetes
Combined Meeting of the 17th European-Society-of-Gene-and-Cell-Therapy/16th German-Society-for-Gene-Therapy/4th German-Society-for-Stem-Cell-Research, Hannover, Almanya, 21 - 25 Kasım 2009, cilt.20, ss.1482-1483
Adenovirus mediated TRAIL gene therapy approach provides sustained insulin expression in STZ-induced diabetic rats
Combined Meeting of the 17th European-Society-of-Gene-and-Cell-Therapy/16th German-Society-for-Gene-Therapy/4th German-Society-for-Stem-Cell-Research, Hannover, Almanya, 21 - 25 Kasım 2009, cilt.20, ss.1471-1472
Alterations in TRAIL ligand and receptor expression profiles in CY-accelerated type 1 diabetes in NOD mice
Combined Meeting of the 17th European-Society-of-Gene-and-Cell-Therapy/16th German-Society-for-Gene-Therapy/4th German-Society-for-Stem-Cell-Research, Hannover, Almanya, 21 - 25 Kasım 2009, cilt.20, ss.1483
In vivo fluorescence imaging as a method to assess pancreatic islet xenograft failure
Combined Meeting of the 17th European-Society-of-Gene-and-Cell-Therapy/16th German-Society-for-Gene-Therapy/4th German-Society-for-Stem-Cell-Research, Hannover, Almanya, 21 - 25 Kasım 2009, cilt.20, ss.1479
TRAIL death receptor-4 and decoy receptors expression on CD8+T cells correlate with the disease severity in rheumatoid arthritis patients
Combined Meeting of the 17th European-Society-of-Gene-and-Cell-Therapy/16th German-Society-for-Gene-Therapy/4th German-Society-for-Stem-Cell-Research, Hannover, Almanya, 21 - 25 Kasım 2009, cilt.20, ss.1471
Monitoring of systemic delivery of adenovirus mediated EGFP transgene expression in mice using fluorescence imaging
Combined Meeting of the 17th European-Society-of-Gene-and-Cell-Therapy/16th German-Society-for-Gene-Therapy/4th German-Society-for-Stem-Cell-Research, Hannover, Almanya, 21 - 25 Kasım 2009, cilt.20, ss.1507
Differential levels of TRAIL ligand and receptor expressions in STZ-induced T1 diabetes in non-obese diabetic (NOD) mice
Combined Meeting of the 17th European-Society-of-Gene-and-Cell-Therapy/16th German-Society-for-Gene-Therapy/4th German-Society-for-Stem-Cell-Research, Hannover, Almanya, 21 - 25 Kasım 2009, cilt.20, ss.1483
Distinctive expression profile of TRAIL and TRAIL receptors in patients with head and neck cancer
Combined Meeting of the 17th European-Society-of-Gene-and-Cell-Therapy/16th German-Society-for-Gene-Therapy/4th German-Society-for-Stem-Cell-Research, Hannover, Almanya, 21 - 25 Kasım 2009, cilt.20, ss.1422-1423
TRAİL ve reseptörlerinin yassı hücreli larenks ve oral kavite kanserleriyle ilişkisi
31. Ulusal Kulak Burun Bogaz ve Bas ve Boyun Cerrahisi Kongresi, Antalya, Türkiye, 28 Ekim - 01 Kasım 2009, ss.34
TRAİL ve reseptörlerinin yassı hücreli larenks ve oral kavite kanserleriyle ilişkisi
31. Ulusal Kulak Burun Bogaz ve Bas ve Boyun Cerrahisi Kongresi, Antalya, Türkiye, 28 Ekim - 01 Kasım 2009, ss.34
Rheumatoid Arthritis disease activity is correlated with TRAIL death receptor-4 and decoy receptor expresions on CD8+T cells
34th Congress of the Federation-of-European-Biochemical-Societies, Prague, Çek Cumhuriyeti, 4 - 09 Temmuz 2009, cilt.276, ss.259
Increased serum sTRAIL level following BevacizumAb treatment is correlated with patient survival in metastatic colon cancer
34th Congress of the Federation-of-European-Biochemical-Societies, Prague, Çek Cumhuriyeti, 4 - 09 Temmuz 2009, cilt.276, ss.301-302
Serum s TRAIL us efor the assessment of the efficacy of BevacizumAb treatment in metastatic colon cancer
1st International Multidisciplinary Cancer Research Congress, Antalya, Türkiye, 21 - 24 Mayıs 2009, ss.8
Tip 1 diyabette alloimmune mononüklear hücre infiltrasyonun gen tedavisiyle baskılanması fonksiyonel adacık-graft ömrünü uzatır
45. Ulusal Diyabet Kongresi, Antalya, Türkiye, 20 - 24 Mayıs 2009, ss.56
Tip 1 diyabette alloimmune mononüklear hücre infiltrasyonun gen tedavisiyle baskılanması fonksiyonel adacık-graft ömrünü uzatır
45. Ulusal Diyabet Kongresi, Antalya, Türkiye, 20 - 24 Mayıs 2009, ss.56
Diyabetik farelere sıçan pankreatik adacıklarının ksenotransplantasyonu normoglisemi sağlamaktadır
45. Ulusal Diyabet Kongresi, Antalya, Türkiye, 20 - 24 Mayıs 2009, ss.76
Diyabetik farelere sıçan pankreatik adacıklarının ksenotransplantasyonu normoglisemi sağlamaktadır
45. Ulusal Diyabet Kongresi, Antalya, Türkiye, 20 - 24 Mayıs 2009, ss.76
Highlights in the molecular pathogenesis of type 1 diabetes
3rd International Congress of Molecular Medicine, İstanbul, Türkiye, 5 - 08 Mayıs 2009, ss.324-325
Highlights in the molecular pathogenesis of type 1 diabetes
3rd International Congress of Molecular Medicine, İstanbul, Türkiye, 5 - 08 Mayıs 2009, ss.324-325
Comparative molecular analysis of TRAIL ligand and receptor expression profiles in cyclophosphamide versus streptozotocin-induced diabetes in non-obese diabetic (NOD) mice
11th European Congress of Endocrinology, İstanbul, Türkiye, 25 - 29 Nisan 2009, ss.336
A novel gene therapy strategy involving immune-modulation relinquished lymphocyte infiltration into islet grafted sites in STZ induced diabetic rats
11th European Congress of Endocrinology, İstanbul, Türkiye, 25 - 29 Nisan 2009, ss.1
Comparative molecular analysis of TRAIL ligand and receptor expression profiles in cyclophosphamide versus streptozotocin-induced diabetes in non-obese diabetic (NOD) mice
11th European Congress of Endocrinology, İstanbul, Türkiye, 25 - 29 Nisan 2009, ss.336
A novel gene therapy strategy involving immune-modulation relinquished lymphocyte infiltration into islet grafted sites in STZ induced diabetic rats
11th European Congress of Endocrinology, İstanbul, Türkiye, 25 - 29 Nisan 2009, ss.1
BevacizumAb tedavisi uygulanan kolon kanserli hastalarda sTRAIL düzeyinin artışı sağ kalım süresi ile ilişkilidir
XVIII. Ulusal Kanser Kongresi, Antalya, Türkiye, 21 - 26 Nisan 2009, ss.410
Clinical significance of TRAIL and its receptor expression profiles on CD4+CD25+Foxp3+Tregs and CD8+CD25+T cells in patients with rheumatoid arthritis
16th Annual Congress of the European-Society-of-Gene-and-Cell-Therapy, Brugge, Belçika, 13 - 16 Kasım 2008, cilt.19, ss.1148-1149
In vivo imaging to detect the duration of adenovirus mediated EGFP transgene expression in allogeneic islet grafts
16th Annual Congress of the European-Society-of-Gene-and-Cell-Therapy, Brugge, Belçika, 13 - 16 Kasım 2008, cilt.19, ss.1121-1122
Prolonged normoglycemia in STZ-induced diabetic rats transplanted with Adenovirus-mediated human TRAIL gene (Ad5hTRAIL) infected islets
16th Annual Congress of the European-Society-of-Gene-and-Cell-Therapy, Brugge, Belçika, 13 - 16 Kasım 2008, cilt.19, ss.1119-1120
Soluble TRAIL concentrations in patients with rheumatoid arthritis
16th Annual Congress of the European-Society-of-Gene-and-Cell-Therapy, Brugge, Belçika, 13 - 16 Kasım 2008, cilt.19, ss.1149
Pancreatic ductal adenocarcinoma (PDAC) patients reveal elevated TRAIL Death Receptor-4 (DR4) and decoy receptor-2 (DcR2) expression correlated with significant cell death
16th Annual Congress of the European-Society-of-Gene-and-Cell-Therapy, Brugge, Belçika, 13 - 16 Kasım 2008, cilt.19, ss.1104
Adenovirus-mediated human TRAIL gene (Ad5hTRAIL) delivery into pancreatic islets provides prolonged normoglycemia in STZ-induced diabetic rats
3. Klinik Pratikte Kok Hucre ve Gen Tedavisi Kongresi, İstanbul, Türkiye, 29 - 01 Mayıs 2008, ss.10
Gene therapy application scenarios to prolong islet-graft survival in patients with type 1 diabetes
3. Klinik Pratikte Kok Hucre ve Gen Tedavisi Kongresi, İstanbul, Türkiye, 29 Mayıs - 01 Haziran 2008, ss.5
Gene therapy mediated apoptosis inducing approaches employing Ad5hTRAIL and a DCR2 siRNA strategy in lung cancer patients
3. Klinik Pratikte Kok Hucre ve Gen Tedavisi Kongresi, İstanbul, Türkiye, 29 Mayıs - 01 Haziran 2008, ss.3
Adenovirus-mediated human TRAIL gene (Ad5hTRAIL) delivery into pancreatic islets provides prolonged normoglycemia in STZ-induced diabetic rats
3. Klinik Pratikte Kok Hucre ve Gen Tedavisi Kongresi, İstanbul, Türkiye, 29 - 01 Mayıs 2008, ss.10
Gene therapy application scenarios to prolong islet-graft survival in patients with type 1 diabetes
3. Klinik Pratikte Kok Hucre ve Gen Tedavisi Kongresi, İstanbul, Türkiye, 29 Mayıs - 01 Haziran 2008, ss.5
Pankreatik adaciklara adenovirus aracili insan TRAIL geni (Ad5hTRAIL) aktarimi STZ induklemeli diyabetik sicanlarda uzun sureli normoglisemi saglar
44. Ulusal Diyabet Kongresi, Antalya, Türkiye, 28 Mayıs - 01 Haziran 2008, ss.1
Tip 1 diyabet hastalarinda gerceklestirilen adacik naklinde graft sagkalimini uzatabilecek gen tedavi senaryolari
44. Ulusal Diyabet Kongresi, Antalya, Türkiye, 28 Mayıs - 01 Haziran 2008, ss.3
Tip 1 diyabet hastalarinda gerceklestirilen adacik naklinde graft sagkalimini uzatabilecek gen tedavi senaryolari
44. Ulusal Diyabet Kongresi, Antalya, Türkiye, 28 Mayıs - 01 Haziran 2008, ss.3
Pankreatik adaciklara adenovirus aracili insan TRAIL geni (Ad5hTRAIL) aktarimi STZ induklemeli diyabetik sicanlarda uzun sureli normoglisemi saglar
44. Ulusal Diyabet Kongresi, Antalya, Türkiye, 28 Mayıs - 01 Haziran 2008, ss.1
TRAILING from molecular diagnostics to prostate cancer gene therapy
XIX Ulusal İmmunoloji Kongresi, Antalya, Türkiye, 21 - 24 Kasım 2007, ss.33
TRAILING from molecular diagnostics to prostate cancer gene therapy
XIX Ulusal İmmunoloji Kongresi, Antalya, Türkiye, 21 - 24 Kasım 2007, ss.33
Adenovirus vectors efficiently deliver TRAIL into pancreatic islets without generating cytotoxic effects
15th Annual Congress of the European-Society-of-Gene-and-Cell-Therapy, Rotterdam, Hollanda, 27 - 30 Ekim 2007, cilt.18, ss.1074
High endogenous TRAIL expression levels in human pancreas is correlated with increased cell death
15th Annual Congress of the European-Society-of-Gene-and-Cell-Therapy, Rotterdam, Hollanda, 27 - 30 Ekim 2007, cilt.18, ss.1074-1075
Comparative analysis of TRAIL and its receptor expression profiles in synoviocytes versus peripheral lymphocytes of patients with rheumatoid arthritis
15th Annual Congress of the European-Society-of-Gene-and-Cell-Therapy, Rotterdam, Hollanda, 27 - 30 Ekim 2007, cilt.18, ss.1091-1092
. “Expression Profile of TRAIL and its Receptors in Breast Cancer patients with invasive ductal carcinoma’’ Vol. 5 (4), EJC Supement Elsevier, 2007.
14th European Cancer Conference, Barcelona, İspanya, 23 - 27 Eylül 2007, ss.2136
Expression profile of TRAIL and its receptors in breast cancer patients with invasive ductal carcinoma
ECCO 14 The European Cancer Conference, Barcelona, İspanya, 23 - 27 Eylül 2007, ss.225-226
Tip 1 diyabet gelişiminde rol alan TNF-Related Apoptosis Inducing Ligand (TRAIL) ölümcül ve yalancı reseptörlerinin normal insan pankreasindaki sentez profili ve artan apoptozis ile korelasyonu
X. Tıbbi Biyoloji ve Genetik Kongresi, Antalya, Türkiye, 6 - 09 Eylül 2007, ss.112
Tip 1 diyabet gelişiminde rol alan TNF-Related Apoptosis Inducing Ligand (TRAIL) ölümcül ve yalancı reseptörlerinin normal insan pankreasindaki sentez profili ve artan apoptozis ile korelasyonu
X. Tıbbi Biyoloji ve Genetik Kongresi, Antalya, Türkiye, 6 - 09 Eylül 2007, ss.112
Tip 1 diyabet gelişiminde rol alan TNF-Related Apoptosis Inducing Ligand (TRAIL) ölümcül ve yalancı reseptörlerinin normal insan pankreasindaki sentez profili ve artan apoptozis ile korelasyonu
X. Tıbbi Biyoloji ve Genetik Kongresi, Antalya, Türkiye, 6 - 09 Eylül 2007, ss.232
Tip 1 diyabette ölümcül ligant aracılı gen tedavi modelinin moleküler etki mekanizması.
43. Ulusal Diyabet Kongresi, Antalya, Türkiye, 9 - 13 Mayıs 2007, ss.45
Yokluğu Tip 1 diyabetle ilişkilendirilmis TNF-Related Apoptosis Inducing Ligand (TRAIL) ölümcül ve yalancı reseptorlerinin normal insan pankreasindaki sentez profili
43. Ulusal Diyabet Kongresi, Antalya, Türkiye, 9 - 13 Mayıs 2007, ss.54
Tip 1 diyabetli hastalarda kullanılacak etkin bir tedavi modelinin geliştirilmesi maksadıyla pankreatik adacıklara adenovirus aracılı TRAİL geni aktarımı
43. Ulusal Diyabet Kongresi, Antalya, Türkiye, 9 - 13 Mayıs 2007, ss.51
Tip 1 diyabette ölümcül ligant aracılı gen tedavi modelinin moleküler etki mekanizması.
43. Ulusal Diyabet Kongresi, Antalya, Türkiye, 9 - 13 Mayıs 2007, ss.45
Tip 1 diyabetli hastalarda kullanılacak etkin bir tedavi modelinin geliştirilmesi maksadıyla pankreatik adacıklara adenovirus aracılı TRAİL geni aktarımı
43. Ulusal Diyabet Kongresi, Antalya, Türkiye, 9 - 13 Mayıs 2007, ss.51
Yokluğu Tip 1 diyabetle ilişkilendirilmis TNF-Related Apoptosis Inducing Ligand (TRAIL) ölümcül ve yalancı reseptorlerinin normal insan pankreasindaki sentez profili
43. ULUSAL DİYABET KONGRESİ, Antalya, Türkiye, 9 - 13 Mayıs 2007, ss.66
Yokluğu Tip 1 diyabetle ilişkilendirilmis TNF-Related Apoptosis Inducing Ligand (TRAIL) ölümcül ve yalancı reseptorlerinin normal insan pankreasindaki sentez profili
43. Ulusal Diyabet Kongresi, Antalya, Türkiye, 9 - 13 Mayıs 2007, ss.54
Upnormal increase in the nuclear NF-kB activity of the rat cavernosal tissue is correlated with diabetes related erectile dysfunction syndrome
XIV Annual Congress of the European Society of Gene Therapy, Atina, Yunanistan, 9 - 12 Kasım 2006, ss.213
A DcR2 siRNA strategy employing three different siRNA constructs in combination defeats adenovirus transferred TRAIL resistance in lung cancer cells
XIV Annual Congress of the European Society of Gene Therapy, Atina, Yunanistan, 9 - 12 Kasım 2006, ss.103
Upnormal increase in the nuclear NF-kB activity of the rat cavernosal tissue is correlated with diabetes related erectile dysfunction syndrome
XIV Annual Congress of the European Society of Gene Therapy, Atina, Yunanistan, 9 - 12 Kasım 2006, ss.213
Differential expression of trail and its receptors in patients with prostate carcinoma
31st Congress of the Federation-of-European-Biochemical-Societies (FEBS), İstanbul, Türkiye, 24 - 29 Haziran 2006, cilt.273, ss.133
Adenovirus delivery of TRAIL effectively destroys synoviocytes of patients with rheumatoid arthritis
31st Congress of the Federation-of-European-Biochemical-Societies (FEBS), İstanbul, Türkiye, 24 - 29 Haziran 2006, cilt.273, ss.134
Adenovirus mediated TRAIL gene delivery as a model for the treatment of patients with diabetes
31st Congress of the Federation-of-European-Biochemical-Societies (FEBS), İstanbul, Türkiye, 24 - 29 Haziran 2006, cilt.273, ss.206
A DCR2 siRNA approach defeats trail resistance in lung cancer cells
31st Congress of the Federation-of-European-Biochemical-Societies (FEBS), İstanbul, Türkiye, 24 - 29 Haziran 2006, cilt.273, ss.133
Mechanism of TRAIL resistance in breast cancer cells for adenovirus mediated gene delivery
Annual Meeting of the American-Association-of-Immunologists, Massachusetts, Amerika Birleşik Devletleri, 12 - 16 Mayıs 2006, cilt.176
DcR2 siRNA yaklaşımı A549 akciğer kanser hücrelerini adenovirus aracılı TRAİL transferine duyarlı kılar
IX. Ulusal Tıbbi Biyoloji Kongresi, Manisa, Türkiye, 24 - 27 Kasım 2005, ss.5
Tip 1 diyabetli hastalar için geliştirilen pankreatik adacık transplantasyonunda adenovirus aracılı TRAİL gen transferinin etkinliği
IX. Ulusal Tıbbi Biyoloji Kongresi, Manisa, Türkiye, 24 - 27 Kasım 2005, ss.66
Tip 1 diyabetli hastalar için geliştirilen pankreatik adacık transplantasyonunda adenovirus aracılı TRAİL gen transferinin etkinliği
IX. Ulusal Tıbbi Biyoloji Kongresi, Manisa, Türkiye, 24 - 27 Kasım 2005, ss.66
Surface TRAIL decoy receptor-4 expression constitutes a resistance to adenovirus delivery of TRAIL in MCF7 breast cancer cells
13th Annual Congress of European Society of Gene Therapy, Prague, Çek Cumhuriyeti, 29 Eylül - 01 Ekim 2005, ss.15
Adenovirus mediated NF-kB inhibiting strategies for the treatment of patients with type 1 diabetes
13th Annual Congress of European Society of Gene Therapy, Prague, Çek Cumhuriyeti, 29 Eylül - 01 Ekim 2005, ss.88
Efficient adenovirus mediated TRAIL gene delivery into pancreatic islets as a model for the treatment of patients with type 1 diabetes
13th Annual Congress of European Society of Gene Therapy, Prague, Çek Cumhuriyeti, 29 Eylül - 01 Ekim 2005, ss.74
TRAIL ligand and receptor expressions are differentially upregulated in prostate carcinoma patients: a significant issue for gene therapy of advanced prostate cancer
13th Annual Congress of European Society of Gene Therapy, Prague, Çek Cumhuriyeti, 29 Eylül - 01 Ekim 2005, ss.22
A DcR2 siRNA approach overcomes TRAIL resistance in A549 lung cancer cells
13th Annual Congress of European Society of Gene Therapy, Prague, Çek Cumhuriyeti, 29 Eylül - 01 Ekim 2005, ss.172
A novel death ligand mediated gene therapy approach for patients with lung cancer
Advances in Molecular Medicine, İstanbul, Türkiye, 3 - 05 Eylül 2005, ss.162
Surface TRAIL Receptor-4 expression correlates with TRAIL resistance in breast cancer cells
Advances in Molecular Medicine, İstanbul, Türkiye, 3 - 05 Eylül 2005, ss.164
Testing the efficacy of a novel adenovirus mediated TRAIL gene therapy approach for the treatment of patients with Type 1 Diabetes
Advances in Molecular Medicine, İstanbul, Türkiye, 3 - 05 Eylül 2005, ss.160
Surface TRAIL Receptor-4 expression correlates with TRAIL resistance in breast cancer cells
Advances in Molecular Medicine, İstanbul, Türkiye, 3 - 05 Eylül 2005, ss.164
Current Progress in Cancer Gene Therapy
XIX Ulusal Biyokimya Kongresi, Antalya, Türkiye, 22 - 25 Nisan 2005, ss.5
Advanced prostate cancer cells display differential NF-kB activation pattern which is the primary determinant of TRAIL resistance
12th Annual Congress of European Society of Gene Therapy, Tampere, Finlandiya, 4 - 07 Kasım 2004, ss.19
Advanced prostate cancer cells display differential NF-kB activation pattern which is the primary determinant of TRAIL resistance
12th Annual Congress of European Society of Gene Therapy, Tampere, Finlandiya, 4 - 07 Kasım 2004, ss.19
Anti HIV drug PDTC genetoxic agents synergistically activate Adeno Associated Virus Type-2 endocytosis and transduction
12th Annual Congress of European Society of Gene Therapy, Tampere, Finlandiya, 4 - 07 Kasım 2004, ss.56
Therapeutic effect of recombinant adenovirus mediated TRAIL gene therapy method in Lung Cancer
12th Annual Congress of European Society of Gene Therapy, Tampere, Finlandiya, 4 - 07 Kasım 2004, ss.22
Resistance to Adenovirus mediated TRAIL gene therapy in breast cancer cells is eliminated by the expression of dominant negative IKKb
12th Annual Congress of European Society of Gene Therapy, Tampere, Finlandiya, 4 - 07 Kasım 2004, ss.20
Akciğer kanserinde recombinant adenovirus aracılı TRAİL gen tedavi metodunun terapötik etkisi
1. Ulusal Klinik Pratikde Kök Hücre ve Gen Tedavisi Kongresi, İstanbul, Türkiye, 7 - 09 Mayıs 2004, ss.128
Hücre içi anti-apoptotik yolun bloke edilmesi meme kanserini adenovirus aracılı TRAİL gen tedavi metoduna karşı duyarlı hale getirdi
1. Ulusal Klinik Pratikde Kök Hücre ve Gen Tedavisi Kongresi, İstanbul, Türkiye, 7 - 09 Mayıs 2004, ss.127
İleri ever meme kanserinin adenovirus aracılı TRAİL gen tedavi metoduna duyarlılaştırma yöntemleri
VI. Ulusal Prenatal Tanı ve Tıbbi Genetik Kongresi, Antalya, Türkiye, 21 - 24 Nisan 2004, ss.4
Akciğer kanserinde yeni bir adenovirus aracılı TNF-alpha gen tedavi metodu
VI. Ulusal Prenatal Tanı ve Tıbbi Genetik Kongresi, Antalya, Türkiye, 21 - 24 Nisan 2004, ss.8
İleri ever prostat kanserinde NFkB yolunun bloke edilmesi TRAİL dirençliliğini kırar
VI. Ulusal Prenatal Tanı ve Tıbbi Genetik Kongresi, Antalya, Türkiye, 21 - 24 Nisan 2004, ss.27
İleri ever prostat kanserinde NFkB yolunun bloke edilmesi TRAİL dirençliliğini kırar
VI. Ulusal Prenatal Tanı ve Tıbbi Genetik Kongresi, Antalya, Türkiye, 21 - 24 Nisan 2004, ss.27
Adenovirus aracılı TRAİL geni aktarımının prostat karsinomanın farklı evreleri üzerindeki etkinliği ve prostat kanserli hastalarda TRAİLe olan direnci kırmak için yeni gen tedavi metotlarının geliştirilmesi
8. Ulusal Tıbbi Biyoloji Kongresi, Adana, Türkiye, 14 - 17 Ekim 2003, ss.3
PTENin Gleson skoru ve PSAya kıyasla prostat kanserindeki prognostik değerinin belirlenmesi.
8. Ulusal Tıbbi Biyoloji Kongresi, Adana, Türkiye, 14 - 17 Ekim 2003, ss.5
Mesane kanser gelişiminde PTENin prognostik değerinin belirlenmesi
8. Ulusal Tıbbi Biyoloji Kongresi, Adana, Türkiye, 14 - 17 Ekim 2003, ss.4
PTENin Gleson skoru ve PSAya kıyasla prostat kanserindeki prognostik değerinin belirlenmesi.
8. Ulusal Tıbbi Biyoloji Kongresi, Adana, Türkiye, 14 - 17 Ekim 2003, ss.5
Mesane kanser gelişiminde PTENin prognostik değerinin belirlenmesi
8. Ulusal Tıbbi Biyoloji Kongresi, Adana, Türkiye, 14 - 17 Ekim 2003, ss.4
Adenovirus aracılı TRAİL geni aktarımının prostat karsinomanın farklı evreleri üzerindeki etkinliği ve prostat kanserli hastalarda TRAİLe olan direnci kırmak için yeni gen tedavi metotlarının geliştirilmesi
8. Ulusal Tıbbi Biyoloji Kongresi, Adana, Türkiye, 14 - 17 Ekim 2003, ss.3
Prostat kanserli olgularda PTEN ekspresyonunun prognostic değeri
XV. Ulusal Kanser Kongresi, Antalya, Türkiye, 23 - 27 Nisan 2003, ss.559
PTEN ekspresyon düzeyinin mesane kanseri gelişimindeki rolü
XV. Ulusal Kanser Kongresi, Antalya, Türkiye, 23 - 27 Nisan 2003, ss.558
PTEN ekspresyon düzeyinin mesane kanseri gelişimindeki rolü
XV. Ulusal Kanser Kongresi, Antalya, Türkiye, 23 - 27 Nisan 2003, ss.558
Prostat kanserli olgularda PTEN ekspresyonunun prognostic değeri
XV. Ulusal Kanser Kongresi, Antalya, Türkiye, 23 - 27 Nisan 2003, ss.559
A new treatment modality for lung cancer; Differential regulation of Rac1 and IKK pathways sensitizes lung cancer cells to TNF mediated apoptosis
9th Annual Meeting of European Society of Gene Therapy, Antalya, Türkiye, 2 - 04 Kasım 2001, ss.149
Kitap & Kitap Bölümleri
Diyabet tedavisinde inkretin tabanlı gen tedavi stratejileri
Geçmişten Geleceğe Diabetes Mellitus, İmamoğlu Ş., Satman İ., Akalın S., Salman S., Yılmaz C., Editör, Türkiye Endokrinoloji Ve Metabolizma Der Yayınları, Ankara, ss.603-614, 2015
Metrikler
BM Sürdürülebilir Kalkınma Amaçları
